psoriasis glp 1 GLP-1 Drugs: Easing While Shedding Pounds The Dermatologist | π₯ GLP-1s
Description
The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course
It causes uncomfortable symptoms after you eat.
This once-weekly treatment supports metabolic balance as part of a structured 3-month care plan
GLP-1 agonists are regularly prescribed by doctors for patients with Type 2 Diabetes. And now theyre the next big thing in the weight loss world.
In this follow-up, were going to look specifically at tirzepatide, one of the more recent and most popular GLP-1 agonists
Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options.
